Argent BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:H5O0 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
10 Sep 24	Buy€303,794	Roby Zomer	Individual		1,258,500	€0.24

Insider Buying: H5O0 insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 993.2%.

Top 21 shareholders own 44.15% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
37.8%	Yifat Steuer	18,293,146	€4.0m	0%	no data
2.67%	Roby Zomer	1,292,321	€283.7k	3,720%	no data
2.05%	Spreadex.com Limited, Asset Management Arm	993,953	€218.2k	0%	0.64%
0.36%	Premier Fund Managers Ltd.	176,203	€38.7k	0%	no data
0.22%	Bioheka Limited	107,000	€23.5k	0%	no data
0.19%	Orca Capital GmbH, Asset Management Arm	94,288	€20.7k	0%	5.69%
0.14%	Shachar Shimony	69,500	€15.3k	0%	no data
0.14%	Mercer Street Capital Partners, LLC	65,600	€14.4k	0%	6.67%
0.11%	Sofia Even	51,000	€11.2k	0%	no data
0.099%	Michael Newton	48,000	€10.5k	0%	no data
0.095%	Chetcuti Holdings Pty Ltd	46,045	€10.1k	0%	no data
0.076%	George Bishay	36,823	€8.1k	0%	no data
0.048%	Ilena Alemao	23,343	€5.1k	0%	no data
0.033%	Fairbrother Holdings Pty Ltd	16,043	€3.5k	0%	no data
0.028%	JEP Pty Ltd	13,676	€3.0k	0%	no data
0.028%	I.B.I Trust Management Ltd.	13,372	€2.9k	0%	no data
0.028%	Gagandeep Singh	13,333	€2.9k	0%	no data
0.027%	Paul Merlo	13,043	€2.9k	0%	no data
0.01%	Ross Grant Walker	4,971	€1.1k	0%	no data
0.0012%	Stephen Parker	600	€131.8	0%	no data
0.00058%	Barclays PLC Private Banking & Investment Banking Investment	283	€61.6	0%	no data